Michele Spinicci to Humans
This is a "connection" page, showing publications Michele Spinicci has written about Humans.
Connection Strength
0.060
-
Superinfection with difficult-to-treat bacteria in COVID-19 patients: a call for compliance with diagnostic and antimicrobial stewardship. Intern Emerg Med. 2021 04; 16(3):789-791.
Score: 0.007
-
Low risk of serological cross-reactivity between dengue and COVID-19. Mem Inst Oswaldo Cruz. 2020; 115:e200225.
Score: 0.007
-
Short article: Safety of targeted prophylaxis strategy in patients with resolved hepatitis B virus infection receiving rituximab for immune-mediated diseases. Eur J Gastroenterol Hepatol. 2018 07; 30(7):756-760.
Score: 0.006
-
Scaling down of a deworming programme among school-age children after a thirty-year successful intervention in the Bolivian Chaco. Trop Med Int Health. 2018 06; 23(6):616-621.
Score: 0.006
-
Seroepidemiological trend of strongyloidiasis in the Bolivian Chaco (1987-2013) in the absence of disease-specific control measures. Trop Med Int Health. 2017 11; 22(11):1457-1462.
Score: 0.006
-
Impaired response to first SARS-CoV-2 dose vaccination in myeloproliferative neoplasm patients receiving ruxolitinib. Am J Hematol. 2021 11 01; 96(11):E408-E410.
Score: 0.002
-
Disentangling the Association of Hydroxychloroquine Treatment with Mortality in Covid-19 Hospitalized Patients through Hierarchical Clustering. J Healthc Eng. 2021; 2021:5556207.
Score: 0.002
-
First-dose mRNA vaccination is sufficient to reactivate immunological memory to SARS-CoV-2 in subjects who have recovered from COVID-19. J Clin Invest. 2021 06 15; 131(12).
Score: 0.002
-
High-dose steroids for the treatment of severe COVID-19. Intern Emerg Med. 2021 08; 16(5):1395-1399.
Score: 0.002
-
Cell-mediated and humoral adaptive immune responses to SARS-CoV-2 are lower in asymptomatic than symptomatic COVID-19 patients. Eur J Immunol. 2020 Dec; 50(12):2013-2024.
Score: 0.002
-
Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent. J Clin Invest. 2020 09 01; 130(9):4694-4703.
Score: 0.002
-
"COVID-19: diagnosis, management and prognosis": a new topical collection of Internal and Emergency Medicine. Intern Emerg Med. 2020 08; 15(5):747-750.
Score: 0.002
-
Prompt Predicting of Early Clinical Deterioration of Moderate-to-Severe COVID-19 Patients: Usefulness of a Combined Score Using IL-6 in a Preliminary Study. J Allergy Clin Immunol Pract. 2020 Sep; 8(8):2575-2581.e2.
Score: 0.002
-
Treatment algorithm for COVID-19: a multidisciplinary point of view. Clin Rheumatol. 2020 Jul; 39(7):2077-2084.
Score: 0.002
-
Early experience of an infectious and tropical diseases unit during the coronavirus disease (COVID-19) pandemic, Florence, Italy, February to March 2020. Euro Surveill. 2020 04; 25(17).
Score: 0.002
-
Focal spleen lesions in visceral leishmaniasis, a neglected manifestation of a neglected disease: report of three cases and systematic review of literature. Infection. 2019 Aug; 47(4):507-518.
Score: 0.002
-
Canine Trypanosoma cruzi infection in the Bolivian Chaco. Parasit Vectors. 2018 Dec 12; 11(1):632.
Score: 0.002
-
High prevalence of carriage of mcr-1-positive enteric bacteria among healthy children from rural communities in the Chaco region, Bolivia, September to October 2016. Euro Surveill. 2018 11; 23(45).
Score: 0.002
-
Novel M. tuberculosis specific IL-2 ELISpot assay discriminates adult patients with active or latent tuberculosis. PLoS One. 2018; 13(6):e0197825.
Score: 0.002
-
Seroprevalence of Hepatitis A Virus, Hepatitis E Virus, and Helicobacter pylori in Rural Communities of the Bolivian Chaco, 2013. Am J Trop Med Hyg. 2018 05; 98(5):1275-1280.
Score: 0.002
-
The role of Quantiferon-TB Gold in-Tube in the diagnosis and treatment monitoring of active tuberculosis. Infect Dis (Lond). 2017 Jun; 49(6):474-477.
Score: 0.001